BGLC vs IRM · rev $9.5M vs P/E 136, rev $3.97B
BioNexus Gene Lab Corp Common stock (BGLC) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
BGLC currently screens at market cap $6.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the BGLC and IRM stock pages for the full models.
Not investment advice.